BusinessElite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended ReleaseBy Nasdaq OMXSep 20, 2017, 12:38 PM UTC
BusinessElite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin®By Nasdaq OMXJan 17, 2017, 1:00 PM UTC
